Cargando…

Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study

BACKGROUND: Empiric antimicrobial therapy (EAMT) using imipenem/colistin is commonly prescribed as a first line therapy in critically ill patients with severe sepsis. We aimed to assess the appropriateness of prescribing imipenem/colistin as EAMT in ICU patients. METHODS: A 3-year observational pros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trifi, Ahlem, Abdellatif, Sami, Abdennebi, Cyrine, Daly, Foued, Nasri, Rochdi, Touil, Yosr, Ben Lakhal, Salah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240296/ https://www.ncbi.nlm.nih.gov/pubmed/30445970 http://dx.doi.org/10.1186/s12941-018-0292-7

Ejemplares similares

Ultrasound variations of diaphragm activity between prone position versus supine position in ventilated patients: a cross-sectional comparative study
por: Trifi, Ahlem, et al.
Publicado: (2020)

Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
por: Abdellatif, Sami, et al.
Publicado: (2016)

Ultrasound assessment of the diaphragm during the first days of mechanical ventilation compared to spontaneous respiration: a comparative study.
por: Trifi, Ahlem, et al.
Publicado: (2021)

Shunt in critically ill Covid-19 ARDS patients: Prevalence and impact on outcome (cross-sectional study)
por: Trifi, Ahlem, et al.
Publicado: (2022)

COVID-19–induced acute kidney injury in critically ill patients: epidemiology, risk factors, and outcome
por: Trifi, Ahlem, et al.
Publicado: (2021)

Beneficial of adding Tocilizumab to standard care in critical forms of Covid-19 pneumonia: Study on paired series
por: Trif, Ahlem, et al.
Publicado: (2022)

Pulse pressure variation and adrenal insufficiency in septic shock
por: Sami, A, et al.
Publicado: (2007)

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
por: Brown, Michelle, et al.
Publicado: (2018)

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
por: Brown, Michelle L, et al.
Publicado: (2020)

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
por: Motsch, Johann, et al.
Publicado: (2020)

Corticoids and ACTH test in septic shock: a prospective study over 15 months
por: Abdellatif, S, et al.
Publicado: (2002)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Passive leg rising and pulse contour monitoring
por: Sami, A, et al.
Publicado: (2006)

The Emergence of Colistin- and Imipenem-Associated Multidrug Resistance in Escherichia Coli Isolates from Retail Meat
por: Iweriebor, Benson Chuks, et al.
Publicado: (2022)

Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital
por: Kabbara, Wissam K, et al.
Publicado: (2015)

Effects of imipenem combined with low-dose cyclophosphamide on the intestinal barrier in septic rats
por: Guo, Peng, et al.
Publicado: (2018)

1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
por: Kaye, Keith, et al.
Publicado: (2018)

In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations
por: Song, Joon Young, et al.
Publicado: (2015)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

Primary Adrenal Lymphoma
por: Kacem, Karima, et al.
Publicado: (2014)

PiCCO monitoring – are two injections enough?
por: Alaya, S, et al.
Publicado: (2007)

Iatrogenic complications in the ICU: prospective study during 17 months
por: Ksouri, H, et al.
Publicado: (2006)

Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
por: Yang, Joe, et al.
Publicado: (2022)

Bacteremia due to Serratia rubidaea in intensive care unit: a case series
por: Mehdi, Asma, et al.
Publicado: (2023)

Colistin Loading Dose in Septic Patients with Gram Negative Infections
por: Alshaya, Abdulrahman I, et al.
Publicado: (2022)

Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
por: Yang, Joe, et al.
Publicado: (2022)

Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock
por: Huang, Yingzi, et al.
Publicado: (2020)

Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?
por: Gage-Brown, Alice, et al.
Publicado: (2022)

Is there any place to corticotropin test in sepsis?
por: Abdellatif, S, et al.
Publicado: (2004)

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
por: López-Pérez, Mario, et al.
Publicado: (2021)

Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility
por: Mashaly, Mervat El-Sayed, et al.
Publicado: (2021)

In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
por: Tang, Hung-Jen, et al.
Publicado: (2015)

In-vitro Effect of Imipenem, Fosfomycin, Colistin, and Gentamicin Combination against Carbapenem-resistant and Biofilm-forming Pseudomonas aeruginosa Isolated from Burn Patients
por: Memar, Mohammad Yousef, et al.
Publicado: (2021)

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
por: Kiani, Masoumeh, et al.
Publicado: (2021)

Integrated design of an aerial soft-continuum manipulator for predictive maintenance
por: Yang, Xinrui, et al.
Publicado: (2022)

Effects of Sub-Minimum Inhibitory Concentrations of Imipenem and Colistin on Expression of Biofilm-Specific Antibiotic Resistance and Virulence Genes in Acinetobacter baumannii Sequence Type 1894
por: Shenkutie, Abebe Mekuria, et al.
Publicado: (2022)

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia
por: Smith, Brandon J, et al.
Publicado: (2019)

Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia
por: Lee, Ching-Chi, et al.
Publicado: (2017)

Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy
por: Leedahl, David D, et al.
Publicado: (2014)

Umbilical cord mesenchymal stem cells enhance the therapeutic effect of imipenem by regulating myeloid-derived suppressor cells in septic mice
por: Long, Xianming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_osoao1341u4bo6eoohfj428mur